BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

835 related articles for article (PubMed ID: 28056758)

  • 1. Thrombotic Management of Antiphospholipid Syndrome: Towards Novel Targeted Therapies.
    Islam MA; Alam F; Wong KK; Kamal MA; Gan SH
    Curr Vasc Pharmacol; 2017; 15(4):313-326. PubMed ID: 28056758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiphospholipid Antibody-Mediated Thrombotic Mechanisms in Antiphospholipid Syndrome: Towards Pathophysiology-Based Treatment.
    Islam MA; Alam F; Sasongko TH; Gan SH
    Curr Pharm Des; 2016; 22(28):4451-69. PubMed ID: 27229722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombotic risk in the antiphospholipid syndrome.
    Lim W
    Semin Thromb Hemost; 2014 Oct; 40(7):741-6. PubMed ID: 25299926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiphospholipid syndrome.
    Lim W
    Hematology Am Soc Hematol Educ Program; 2013; 2013():675-80. PubMed ID: 24319251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombosis and Anti-phospholipid Syndrome: a 5-Year Update on Treatment.
    Chighizola CB; Meroni PL
    Curr Rheumatol Rep; 2018 May; 20(7):44. PubMed ID: 29850957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends.
    Erkan D; Aguiar CL; Andrade D; Cohen H; Cuadrado MJ; Danowski A; Levy RA; Ortel TL; Rahman A; Salmon JE; Tektonidou MG; Willis R; Lockshin MD
    Autoimmun Rev; 2014 Jun; 13(6):685-96. PubMed ID: 24468415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status and future prospects for the treatment of antiphospholipid syndrome.
    Al Marzooqi A; Leone A; Al Saleh J; Khamashta M
    Expert Rev Clin Immunol; 2016 Sep; 12(9):927-35. PubMed ID: 27117597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiphospholipid syndrome - an update.
    Linnemann B
    Vasa; 2018 Oct; 47(6):451-464. PubMed ID: 30205764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current management of antiphospholipid syndrome-related thrombosis.
    Puente D; Pombo G; Forastiero R
    Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1551-8. PubMed ID: 19954317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of direct oral anticoagulants in 56 patients with antiphospholipid syndrome.
    Malec K; Góralczyk T; Undas A
    Thromb Res; 2017 Apr; 152():93-97. PubMed ID: 27989533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition and management of antiphospholipid syndrome.
    Gerosa M; Meroni PL; Erkan D
    Curr Opin Rheumatol; 2016 Jan; 28(1):51-9. PubMed ID: 26599382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostics and treatment of thrombotic antiphospholipid syndrome (APS): A personal perspective.
    Pengo V; Denas G
    Thromb Res; 2018 Sep; 169():35-40. PubMed ID: 30007134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of Antiphospholipid Syndrome.
    Arachchillage DRJ; Pericleous C
    Semin Thromb Hemost; 2023 Apr; 49(3):295-304. PubMed ID: 36646109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Management of the antiphospholipid syndrome in adults].
    Doms J; Horisberger A; Ribi C
    Rev Med Suisse; 2020 Apr; 16(689):670-674. PubMed ID: 32270932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of antiphospholipid syndrome beyond anticoagulation.
    Dobrowolski C; Erkan D
    Clin Immunol; 2019 Sep; 206():53-62. PubMed ID: 29510235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of direct oral anticoagulants in antiphospholipid syndrome.
    Cohen H; Efthymiou M; Isenberg DA
    J Thromb Haemost; 2018 Jun; 16(6):1028-1039. PubMed ID: 29624847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and management of the antiphospholipid syndrome.
    Chaturvedi S; McCrae KR
    Blood Rev; 2017 Nov; 31(6):406-417. PubMed ID: 28784423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging Therapies in Antiphospholipid Syndrome.
    Hubben A; McCrae KR
    Transfus Med Rev; 2022 Oct; 36(4):195-203. PubMed ID: 36272841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update on the biologics for the treatment of antiphospholipid syndrome.
    Yun Z; Duan L; Liu X; Cai Q; Li C
    Front Immunol; 2023; 14():1145145. PubMed ID: 37275894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of Recurrent Thrombosis in Antiphospholipid Syndrome: Different from the General Population?
    Legault KJ; Ugarte A; Crowther MA; Ruiz-Irastorza G
    Curr Rheumatol Rep; 2016 May; 18(5):26. PubMed ID: 27032789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.